20. October 2015
Press release: Additional subsidy funding for clinical development of a celiac disease drug
Read more | Document
20. October 2015
Pressemitteilung: Zusätzliche Fördermittel für die klinische Entwicklung eines Zöliakie-Medikamentes
Read more | Document
29. September 2015
New: Recombinant Gliadin Peptides
Read more | Document
22. September 2015
Press Release: Cooperation between Zedira and Cardiff University - Transglutaminase 6 is the focus of new research into ataxia
Read more | Document
18. June 2015
New website launched
Read more | Document
2. March 2015
Press Release: Dr. Falk Pharma and Zedira enter phase I clinical trials for a celiac disease drug
Read more | Document
2. March 2015
Pressemitteilung: Dr. Falk Pharma und Zedira starten klinische Phase I zur medikamentösen Behandlung der Zöliakie
Read more | Document
3. February 2015
Press release: Zedira receives further funding to develop Factor XIIIa-blockers for safe anticoagulation
Read more | Document

News

Blog

Events